| Voltaren Gel Receives US Regulatory Approval As The First Approved Topical Prescription Treatment For Pain Associated ...
Voltaren Gel (diclofenac sodium topical gel) 1% has received US regulatory approval as the first topical prescription treatment that patients can apply directly to sites of pain associated with osteoarthritis.
The US Food and Drug Administration (FDA) granted the approval for Voltaren Gel, which is a non-steroidal anti-inflammatory (NSAID) medication, for use in treating pain associated with osteoarthritis in joints amenable to topical treatment, such as the knees and those of the hands.
Osteoarthritis is a chronic condition characterized by the breakdown of cartilage in the joint.
Clinical trials have demonstrated Voltaren Gel to be highly effective in treating osteoarthritis pain in the hands and knees, which are the body's most commonly affected joints.
Jehovah's Witness mother dies after refusing blood
A 22-year-old woman died within a few hours of giving birth to twins because, as a Jehovah's Witness, she was not allowed to accept a blood transfusion, it emerged today. Emma Gough suffered severe blood loss after giving birth to a boy and girl at the Royal Hospital in Shrewsbury ten days ago. Doctors and medics begged her 24-year-old husband, Anthony, and other relatives to overrule a form she had ticked insisting that she should not be given blood because of her faith. But the family refused to do so. .
USC School Of Dentistry Researchers Discover Link Between Oral Cancer And Ethnicity
Clinicians from the USC School of Dentistry unravel connection between the incidence of oral cancer and race and ethnicity-- as part of first epidemiological study of oral cancer in California. Dr. Satish Kumar and Dr.Parish Sedghizadeh, clinical professors in the school's Division of Diagnostic Sciences, gleaned through 20 years of records from the California Cancer Registry (CCR)-the state's cancer surveillance database-for the incidence rates of invasive squamous cell carcinoma, the most common form of oral cancer.
Their findings will be published in an upcoming issue of the journal Oral Surgery, Oral Medicine, Oral Pathology, Oral Radiology and Endodontology and are currently available online at http://www.ooooe.net.
Kumar and Sedghizadeh theorized that groups who engaged in these high-risk behaviors would also experience higher rates of oral cancer.
Medical facilities snuff out smoking
The road signs, bright and conspicuous, will be posted Thursday at all driveway entrances to Providence Alaska Medical Center. Outside its doors will be more signs with the polite but firm message: "This is a no smoking campus." And, in places where smokers used to huddle, near entrance-way trash cans, reminder stickers will be placed where cigarette butts were once crushed. .
How To Beat The Flu Virus
SOME people call it the tenner test - the unscientific way of determining whether you have the flu or a common cold. Imagine you saw a £10 note lying in your garden. If you have a cold you'll go and retrieve it, but if you have the flu you'll say 'stuff it' and leave it lying there. Because if sniffing and sneezing characterise a common cold, bone-shaking shivers, pounding headaches and excruciating tiredness signify the flu. The cosy option of snuggling in front of the TV is not an option when the flu virus is coursing through your veins leaving you too ill to move and exhausted after waves of hot fever and cold trembles. Only those who have truly suffered the flu understand its debilitating effects - and they hope the rest of us never experience it.
Allergen Immunotherapy Evolves As Faster, Safer And Longer Lasting Treatment
Time tested for a century, allergen immunotherapy has evolved into revolutionary methods of administration, as well as faster, safer and longer lasting treatments according to the latest research presented at the Annual Meeting of the American College of Allergy, Asthma and Immunology (ACAAI) in Dallas.
Recent studies have shown subcutaneous immunotherapy, or allergy shots, may prevent the progression of allergic disease and reduce the risk of developing asthma; reduce the need for medication; reduce utilization and costs of health care services; and provide long term remission after discontinuation of treatment.
"In a recent study of allergy immunotherapy among Florida Medicaid enrolled children with allergic rhinitis, there was a significant reduction in utilization and costs of health care services, especially inpatient care," said Linda S.
|
